FreeIn the Archives In an oral history now taken down by FDA, Andrew von Eschenbach recounts his stint as the head of both FDA and NCI—simultaneously April 04, 2025Vol.51 No.13By Jacquelyn Cobb
FreeIn the Archives Breast cancer activists in the 90s got DOD to fund cancer research—now that program has been gutted March 28, 2025Vol.51 No.12
FreeIn the Archives In 1990, “political oncologist” Helene Brown predicted the future. Did she get it right? March 21, 2025Vol.51 No.11By Katie Goldberg
FreeTrials & Tribulations The new therapeutic imperative in cancer management: Sequence, biosimulate, treat March 07, 2025Vol.51 No.09By Michael P. Castro
FreeIn the Archives In an oral history now taken down by FDA, Peter Greenwald discusses controversy over health claims on Kellogg’s All-Bran February 28, 2025Vol.51 No.08By Jacquelyn Cobb
Black History MonthConversation with The Cancer LetterFree Brian Rivers: Celebrating Black history reinforces the dynamic culture of America“It gives America, in part, its identity.” February 21, 2025Vol.51 No.07By Jacquelyn Cobb
FreeObituary John Zaia, virologist and gene therapy pioneer, dies at 82 February 21, 2025Vol.51 No.07By Samantha Bonar and Abe Rosenberg
Black History MonthFreePodcastThe Directors On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centersThe Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty February 14, 2025Vol.51 No.06By Paul Goldberg
FreeGuest Editorial Preparing to take care of each other in ways we never imagined February 14, 2025Vol.51 No.06By W. Kimryn Rathmell
